A detailed history of Vident Advisory, LLC transactions in Viatris Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 102,812 shares of VTRS stock, worth $1.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
102,812
Previous 104,632 1.74%
Holding current value
$1.19 Million
Previous $1.25 Billion 12.52%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $18,291 - $21,876
-1,820 Reduced 1.74%
102,812 $1.09 Billion
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $266,929 - $320,458
-23,685 Reduced 18.46%
104,632 $1.25 Billion
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $117,351 - $145,183
-13,381 Reduced 9.44%
128,317 $1.39 Billion
Q3 2023

Feb 21, 2024

BUY
$9.59 - $11.35 $128,323 - $151,874
13,381 Added 10.43%
141,698 $1.4 Billion
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $1.36 Million - $1.61 Million
141,698 New
141,698 $1.4 Billion

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.